Taipei – The cancer patient who was treated with the Immune Checkpoint Inhibitor (ICI) has a risk of psoriasis. Dies zeigt eine Kohortenstudie aus Taiwan, deren Ergebnisse jetzt in JAMA Dermatology verkächt wurden (2024; DOI: 10.1001/jamadermatol.2024.4129). “The Immune Checkpoint Inhibitor has revolutionized Cancer Therapy, and it has improved the immune system, which does not work as it should…